| Sector |
Healthcare
|
Compare with Sector peers |
| Industry |
Hospital & Healthcare Services
|
Compare with Industry peers |
| Website | http://www.tejnaksh.com | |
| Financial Indicators | ||
|---|---|---|
| Market Cap | 89.08 Cr. | |
| Earnings per share (EPS) | 2.02 | Trailing Twelve Months Ending 2021-03 |
| Price-Earning Ratio (PE) | 43.39 | Trailing Twelve Months Ending 2021-03 |
| Industry PE | 227.26 | Trailing Twelve Months Ending 2021-03 |
| Book Value / Share | 17.05 | Trailing Twelve Months Ending 2021-03 |
| Price to Book Value | 5.14 | Calculated using Price: 87.70 |
| Dividend Yield | 0.00 | Period Ending 2020-03 |
| No. of Shares Subscribed | 1.02 Cr. | 10,156,800 Shares |
| FaceValue | 10 | |
| Company Profile | ||
|
The company was incorporated in Mumbai as “Tejnaksh Healthcare Private Limited” on February 18, 2008 as a private limited company under provision of companies Act 1956. The company was converted in to a Public Limited Company and consequently the name was changed to “Tejnaksh Healthcare Limited' vide fresh certificate of incorporation dated 10th March, 2015 issued by the Registrar of Companies, Mumbai, Maharashtra. The company’s Managing Director and Promoter Ashish Vishwas Rawandale is listed in Guinness World Records (twice), Ripley’s believe it or not, Limca book of records, India book of records (multiple records), Asia book of records, World amazing records and World record academy for various achievements and innovations in urology. The company is a professionally managed and growing organization. The company runs an Institute of Urology, an ISO certified the international level Urology hospital, located in the heart of Dhule city, Maharashtra, India. The 24000 Sq. Ft. campus has a four storey building which houses the complete Urology setup. It provides a comprehensive range of services from consultations and investigations to treatment for Urology. The company is equipped with all latest equipment and provides the whole range of services, the patients from local area do not feel the need to go to metropolitan areas for urological problems. The Institute is recognized by National board of examinations for DNB (Urology). The Institute boasts of 150 research publications and 23 innovations. Business area of the company The company is an integrated healthcare delivery service provider, committed to delivering quality healthcare services to its patients in modern facilities. Its operations are divided across four key vertical streams in healthcare delivery, namely - “Pediatric Urology”, “Adult Urology (Male, Female)”, “Andrology and Sexual Dysfunction” and “Nephrology, Dialysis and Renal Transplant”. It offers a gamut of more than 65 healthcare services under these streams. A base of over 65 employees and consultants supports its healthcare facility network. The company’s healthcare facilities use advanced technology and its doctors, nurses and other healthcare professionals follow treatment protocols that match international standards. A majority of its healthcare facilities provide secondary, tertiary and quaternary healthcare services to patients. Some of its healthcare facilities provide super speciality quaternary healthcare to patients in key specialty areas such as Pediatric Urology and Adult Urology (Male, Female).
|
||
Company Profile
The company was incorporated in Mumbai as “Tejnaksh Healthcare Private Limited” on February 18, 2008 as a private limited company under provision of companies Act 1956. The company was converted in to a Public Limited Company and consequently the name was changed to “Tejnaksh Healthcare Limited' vide fresh certificate of incorporation dated 10th March, 2015 issued by the Registrar of Companies, Mumbai, Maharashtra. The company’s Managing Director and Promoter Ashish Vishwas Rawandale is listed in Guinness World Records (twice), Ripley’s believe it or not, Limca book of records, India book of records (multiple records), Asia book of records, World amazing records and World record academy for various achievements and innovations in urology.
The company is a professionally managed and growing organization. The company runs an Institute of Urology, an ISO certified the international level Urology hospital, located in the heart of Dhule city, Maharashtra, India. The 24000 Sq. Ft. campus has a four storey building which houses the complete Urology setup. It provides a comprehensive range of services from consultations and investigations to treatment for Urology. The company is equipped with all latest equipment and provides the whole range of services, the patients from local area do not feel the need to go to metropolitan areas for urological problems. The Institute is recognized by National board of examinations for DNB (Urology). The Institute boasts of 150 research publications and 23 innovations.
Business area of the company
The company is an integrated healthcare delivery service provider, committed to delivering quality healthcare services to its patients in modern facilities. Its operations are divided across four key vertical streams in healthcare delivery, namely - “Pediatric Urology”, “Adult Urology (Male, Female)”, “Andrology and Sexual Dysfunction” and “Nephrology, Dialysis and Renal Transplant”. It offers a gamut of more than 65 healthcare services under these streams. A base of over 65 employees and consultants supports its healthcare facility network. The company’s healthcare facilities use advanced technology and its doctors, nurses and other healthcare professionals follow treatment protocols that match international standards. A majority of its healthcare facilities provide secondary, tertiary and quaternary healthcare services to patients. Some of its healthcare facilities provide super speciality quaternary healthcare to patients in key specialty areas such as Pediatric Urology and Adult Urology (Male, Female).
| 1 Day |
|
+2.50% |
| 1 Week |
|
+4.76% |
| 1 Month |
|
+29.99% |
| 3 Month |
|
+35.38% |
| 6 Month |
|
+66.82% |
| 1 Year |
|
+141.10% |
| 2 Year |
|
+10.41% |
| 5 Year |
|
+375.93% |
| 5 years | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | |
| Return on Equity (%) | 21.17 | 26.68 | 34.98 | 26.93 | 15.10 | |
| Return on Capital Employed (%) | 34.00 | 29.35 | 32.66 | 27.59 | 17.78 | |
| Return on Assets (%) | 19.32 | 16.96 | 17.97 | 14.93 | 9.10 |
| Particulars | 5 years | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. |
| Shh. Funds | 6 | 8 | 10 | 13 | 15 | |
| Non Curr. Liab. | 0 | 7 | 6 | 6 | 7 | |
| Curr. Liab. | 0 | 1 | 3 | 2 | 2 | |
| Minority Int. | 0 | 0 | 0 | 0 | ||
| Equity & Liab. | 7 | 16 | 20 | 22 | 25 | |
| Non Curr. Assets | 6 | 14 | 17 | 18 | 18 | |
| Curr. Assets | 1 | 2 | 3 | 5 | 7 | |
| Misc. Exp. not W/O | ||||||
| Total Assets | 7 | 16 | 20 | 22 | 25 |
| Particulars | 5 years | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. |
| Net Sales | 5 | 7 | 14 | 20 | 17 | |
| Other Income | 0 | 0 | 0 | 2 | 1 | |
| Total Income | 5 | 7 | 15 | 21 | 17 | |
| Total Expenditure | -2 | -4 | -9 | -16 | -13 | |
| PBIDT | 2 | 3 | 6 | 6 | 4 | |
| Interest | 0 | -1 | -1 | -1 | ||
| Depreciation | 0 | 0 | 0 | -1 | -1 | |
| Taxation | -1 | -1 | -1 | -1 | -1 | |
| Exceptional Items | ||||||
| PAT | 1 | 2 | 3 | 3 | 2 |
| Particulars | 5 years | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. |
| Cash Fr. Operatn. | 4 | 2 | 4 | 3 | 1 | |
| Cash Fr. Inv. | -3 | -8 | -3 | -2 | -1 | |
| Cash Fr. Finan. | 0 | 6 | -1 | -2 | 0 | |
| Net Change | 0 | 1 | 1 | -1 | 0 | |
| Cash & Cash Eqvt | 0 | 1 | 2 | 1 | 1 |
|
Thu, 22 Jul 2021
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 In accordance with Regulation 74 (5) of the SEBI (Depositories and Participants) Regulations 2018 Please find enclosed herewith certificate received from Cameo Corporate Services Limited (RTA) for the Quarter ended June 30 2021. Please take the same on your record. |
||||||||||||||
|
Sat, 17 Jul 2021
Statement Of Investor Complaints For The Quarter Ended June 2021
|
||||||||||||||
|
Sat, 17 Jul 2021
Shareholding for the Period Ended June 30 2021 Tejnaksh Healthcare Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30 2021. For more details kindly Click here |
| Fri, 30 Jul 2021 |
Stock Outperforming Benchmark Index in both 1 Week and 3 Month
|
Stock Outperforming Sectoral Index in both 1 Week and 3 Month
|
Strongly Outperforming Benchmark Index
|
Strongly Outperforming Sectoral Index
|
Close Within 2 Year High Zone
|
Equities
M.F.
Sectors